Showing results (201-210 of 379) with videos related to

Sort By:
Pageof 38
Diabetes, Obesity & Metabolism|September 6, 2023
The effects of canagliflozin in type 2 diabetes in subgroups defined by population-specific body mass index: Insights from the CANVAS Program and CREDENCE trialJie Yu, Arianne N Sweeting, Chris Gianacas, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 5, 2024
The Point-of-Care Peritoneal Dialysis System Early Evaluation Study (POC-PDEE): A pilot proof-of-principal study of the Ellen Medical Devices Point-of-Care affordable peritoneal dialysis systemBenjamin Talbot, Simon Davies, Jenny Burman, et al.
Kidney International Reports|February 12, 2024
The Prevalence of CKD in Australian Primary Care: Analysis of a National General Practice DatasetMin Jun, James Wick, Brendon L Neuen, et al.
The New England Journal of Medicine|October 25, 2024
Alternative Complement Pathway Inhibition with Iptacopan in IgA NephropathyVlado Perkovic, Jonathan Barratt, Brad Rovin, et al.
Annals of Internal Medicine|March 21, 2012
Effects of antiplatelet therapy on mortality and cardiovascular and bleeding outcomes in persons with chronic kidney disease: a systematic review and meta-analysisSuetonia C Palmer, Lucia Di Micco, Mona Razavian, et al.
Hypertension (Dallas, Tex. : 1979)|December 21, 2018
Acute Increases in Serum Creatinine After Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes MellitusToshiaki Ohkuma, Min Jun, Anthony Rodgers, et al.
Kidney International|July 16, 2017
Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease-Improving Global Outcomes (KDIGO) Controversies ConferenceColin Baigent, William G Herrington, Josef Coresh, et al.
Lancet (London, England)|November 13, 2015
Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysisXinfang Xie, Emily Atkins, Jicheng Lv, et al.
Journal of Hypertension|February 8, 2017
Side effects and tolerability of combination blood pressure lowering according to blood pressure levels: an analysis of the PROGRESS and ADVANCE trialsEmily R Atkins, Yoichiro Hirakawa, Abdul Salam, et al.
The Lancet. Diabetes & Endocrinology|September 10, 2019
SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysisBrendon L Neuen, Tamara Young, Hiddo J L Heerspink, et al.
Pageof 38